Vascular endothelial growth factor A (VEGF-A) is a potent proangiogenic cytokine elevated in patients with peripheral artery disease (PAD). A new study links impaired vascular regrowth in PAD to increased expression of an antiangiogenic splice variant of VEGF-A.
References
Annex, B.H. Nat. Rev. Cardiol. 10, 387–396 (2013).
Kikuchi, R. et al. Nat. Med. 20, 1464–1471 (2014).
Shimamura, M., Nakagami, H., Koriyama, H. & Morishita, R. Biomed. Res. Int. 2013, 186215 (2013).
Makin, A.J., Chung, N.A.Y., Silverman, S.H. & Lip, G.Y.H. Clin. Sci. 104, 397–404 (2003).
Bates, D.O. et al. Cancer Res. 62, 4123–4131 (2002).
Peiris-Pagès, M. Cell Adh. Migr. 6, 561–568 (2012).
Volpi, N. et al. Mediators Inflamm. 2013, 219313 (2013).
Jones, W.S. et al. Vasc. Med. 17, 94–100 (2012).
Kikuchi, A., Yamamoto, H., Sato, A. & Matsumoto, S. Acta Physiol. (Oxf.) 204, 17–33 (2012).
Stefater, J.A. III et al. Nature 474, 511–515 (2011).
Ouchi, N. et al. Science 329, 454–457 (2010).
Merdzhanova, G. et al. Oncogene 29, 5392–5403 (2010).
Rieder, D. et al. Cell. Mol. Life Sci. 71, 1741–1759 (2014).
Yoshida, K. et al. Nature 478, 64–69 (2011).
Nowak, D.G. et al. J. Cell Sci. 121, 3487–3495 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Boucher, J., Bautch, V. Antiangiogenic VEGF-A in peripheral artery disease. Nat Med 20, 1383–1385 (2014). https://doi.org/10.1038/nm.3767
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3767
- Springer Nature America, Inc.
This article is cited by
-
VEGF-A splice variants bind VEGFRs with differential affinities
Scientific Reports (2020)
-
Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma
Applied Microbiology and Biotechnology (2018)